loader
Please Wait
Applying Filters...

Looking for 03124_RIEDEL? Find Controlled & Modified Release used in 03124_RIEDEL to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 71Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SPI Pharma

02 5Nanjing Well Pharmaceutical

03 3Actylis

04 2Aeon Procare

05 1Alcedo Pharmachem

06 24BASF

07 3Corel Pharma Chem

08 4Finar

09 1Huzhou Sunflower Pharmaceutical

10 2Ideal Cures

11 9Kerry

12 1Kima Chemical

13 1Lonza Capsugel

14 2Nomisma Healthcare

15 2Novo Excipients

16 1Sigachi Industries

17 5The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

03

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed
blank

04

arrow
Aus. Peptide Conference
Not Confirmed

05

arrow
Aus. Peptide Conference
Not Confirmed

06

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

08

arrow
Aus. Peptide Conference
Not Confirmed

09

arrow
Aus. Peptide Conference
Not Confirmed
arrow
Aus. Peptide Conference
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank